FRANCISCO JAVIER
LÓPEZ LONGO
Ikertzailea 2019-(e)ra arte
University of California Los Angeles
Los Ángeles, Estados UnidosUniversity of California Los Angeles-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 10, pp. 963-974